Evidence map›Paper›PMID 28265379›Full record

ArticleClinical case reports2017

Familial hypertrophic cardiomyopathy associated with a new mutation in gene MYBPC3.

Esther Aurensanz Clemente, Ariadna Ayerza Casas, Cecilia García Lasheras, Feliciano Ramos Fuentes, Ines Bueno Martínez, Juana Pelegrín Díaz, Pablo Ruiz Frontera, Lorenzo Montserrat Iglesias

Abstract readCase Reports
PubMed Full text at PMC Publisher
In one paragraph

Article in Clinical case reports, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Esther Aurensanz ClementeDepartment of Pediatrics HCU Lozano Blesa Zaragoza Spain.ORCID 0000-0002-1521-9553
Ariadna Ayerza CasasDepartment of Pediatrics HCU Lozano Blesa Zaragoza Spain.
Cecilia García LasherasDepartment of Pediatrics HCU Lozano Blesa Zaragoza Spain.
Feliciano Ramos FuentesDepartment of Pediatrics HCU Lozano Blesa Zaragoza Spain.
Ines Bueno MartínezDepartment of Pediatrics HCU Lozano Blesa Zaragoza Spain.
Juana Pelegrín DíazDepartment of Cardiology HCU Lozano Blesa Zaragoza Spain.
Pablo Ruiz FronteraIntensive Care Unit HU Miguel Servet Zaragoza Spain.
Lorenzo Montserrat IglesiasScientific Department Health in Code A Coruña Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

We think that the main interests of this study are the report of a new mutation in gene MYBPC3 as a cause of Hypertrophic cardiomyopathy (HMC), and the verification of the fact that not always is the number of mutations related to the severity of the disease.

Indexed as

Geneticshypertrophic cardiomyopathyMYH7myosin‐binding protein C

Identifiers

PMID28265379
PMCPMC5331257

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.